HEALTH PROMOTION AND DISEASE PREVENTION Pharmacotherapy Self-Assessment Program, 5th Edition

1. Discuss the implications of the human genome project and the advent of pharmacogenomics for disease prevention and health promotion initiatives for substance abuse prevention. 2. Outline the Food and Drug Administration’s (FDA) five-part strategic action plan, Protect and Advance America’s Health. 3. Determine when pharmacotherapies are indicated for disease treatment and/or disease prevention and when they are not indicated because of excessive risk or contraindications. 4. Counsel an alcoholic pregnant woman in her first trimester about the risks to her unborn fetus of continued alcohol consumption. 5. Analyze the design, efficacy, and cost of model substance abuse prevention programs. 6. Recommend drug therapy regimens for disease prevention or health promotion when appropriate. 7. Describe the clinical pharmacist’s role in disease state management programs for disease prevention and health promotion.